
1 min read
NEW CLASSIFICATION SYSTEM DEVELOPED FOR REGENERATIVE CELL-BASED THERAPIES
Dr. Cato T. Laurencin, CEO of The Connecticut Convergence Institute for Translation in Regenerative Engineering at UConn Health, has created a new classification system for cell-based therapies. The objective was to create a strategy that will benefit patients, encourage regulatory efforts, and further inform the scientific community, according to...
Read More